114 related articles for article (PubMed ID: 31595101)
1. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
[TBL] [Abstract][Full Text] [Related]
2. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the Phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: Stability testing.
Samkoe KS; Hull S; Elliott J; Sardar HS; Gunn J; Linos K; Tafe L; Harris B; Feldwisch J; Pogue BW; Roberts D; Henderson E; Paydarfar J; Paulsen K
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 36051445
[TBL] [Abstract][Full Text] [Related]
7. Dual-agent fluorescent labeling of soft-tissue sarcomas improves the contrast based upon targeting both interstitial and cellular components of the tumor milieu.
Sardar HS; Zai Q; Xu X; Gunn JR; Pogue BW; Paulsen KD; Henderson ER; Samkoe KS
J Surg Oncol; 2020 Dec; 122(8):1711-1720. PubMed ID: 32885452
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas.
Streeter SS; Xu X; Hebert KA; Werth PM; Hoopes PJ; Jarvis LA; Pogue BW; Paulsen KD; Samkoe KS; Henderson ER
Mol Imaging Biol; 2024 Apr; 26(2):272-283. PubMed ID: 38151580
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
10. Paired-agent imaging for detection of head and neck cancers.
Samkoe KS; Park Y; Marra K; Chen EY; Tichauer KM
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10853():. PubMed ID: 31686720
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomas.
Henderson ER; Werth P; Xu X; Jarvis LA; Paulsen KD; Hoopes PJ; Rosenthal EL; Pogue BW; Samkoe KS
Proc SPIE Int Soc Opt Eng; 2022; 119430():. PubMed ID: 36052271
[TBL] [Abstract][Full Text] [Related]
12. Paired-agent imaging as a rapid
Torres VC; Hodge S; Levy JJ; Vaickus LJ; Chen EY; LeBouef M; Samkoe KS
Front Oncol; 2023; 13():1196517. PubMed ID: 37427140
[TBL] [Abstract][Full Text] [Related]
13. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery.
Xu X; Samkoe KS; Henderson ER
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 32483396
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.
Samkoe KS; Bates BD; Tselepidakis NN; DSouza AV; Gunn JR; Ramkumar DB; Paulsen KD; Pogue BW; Henderson ER
J Biomed Opt; 2017 Dec; 22(12):1-12. PubMed ID: 29274143
[TBL] [Abstract][Full Text] [Related]
15. Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization.
Samkoe KS; Bates BD; Elliott JT; LaRochelle E; Gunn JR; Marra K; Feldwisch J; Ramkumar DB; Bauer DF; Paulsen KD; Pogue BW; Henderson ER
Cancer Control; 2018; 25(1):1073274817752332. PubMed ID: 29334791
[TBL] [Abstract][Full Text] [Related]
16. Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules.
Elliott JT; Dsouza AV; Marra K; Pogue BW; Roberts DW; Paulsen KD
Biomed Opt Express; 2016 Sep; 7(9):3280-3288. PubMed ID: 27699098
[TBL] [Abstract][Full Text] [Related]
17. Comparison of detection sensitivity of near infrared (NIR) surgical imaging systems using a connective tissue phantom model.
Sardar HS; Zai Q; Gunn J; Pogue B; Paulsen K; Samkoe K; Henderson E
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 32296255
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
20. First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.
Sörensen J; Sandberg D; Sandström M; Wennborg A; Feldwisch J; Tolmachev V; Åström G; Lubberink M; Garske-Román U; Carlsson J; Lindman H
J Nucl Med; 2014 May; 55(5):730-5. PubMed ID: 24665085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
